title: Facilitating access of AIDS drugs while maintaining strong patent protection.
abstract: The AIDS pandemic has thrust the subject of patent protection into the spotlight, a spotlight that has attracted the attention of broad audience including interested parties from the political, legal, and medical communities. Can the United States' scheme of strong patent protection for pharmaceutical products withstand the increased attention?
authors.forename: D
authors.initials: D
authors.lastname: Ziker
mesh_terms: D019380:Anti-HIV Agents / Q000191:economics* / Q000600:supply & distribution*; D003906:Developing Countries; D004059:Diffusion of Innovation; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D038622:Internationality; D008004:Licensure; D010330:Patents as Topic; D011640:Public Policy; D012106:Research / Q000191:economics; D014481:United States
chemical_list: D019380:Anti-HIV Agents